Skip to main content
EMBO Molecular Medicine logoLink to EMBO Molecular Medicine
. 2024 Sep 6;16(10):2653. doi: 10.1038/s44321-024-00125-y

Author Correction: SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function

Mihyun Bae 1,#, Junyeop Daniel Roh 2,#, Youjoung Kim 2, Seong Soon Kim 3, Hye Min Han 4, Esther Yang 5, Hyojin Kang 6, Suho Lee 1, Jin Yong Kim 5, Ryeonghwa Kang 2, Hwajin Jung 1, Taesun Yoo 1, Hyosang Kim 2, Doyoun Kim 1, Heejeong Oh 2, Sungwook Han 2, Dayeon Kim 7, Jinju Han 7, Yong Chul Bae 4, Hyun Kim 5, Sunjoo Ahn 3, Andrew M Chan 8, Daeyoup Lee 2, Jin Woo Kim 2, Eunjoon Kim 1,2,
PMCID: PMC11473947  PMID: 39242973

Abstract

graphic file with name 44321_2024_125_Figa_HTML.jpg


Correction to: EMBO Molecular Medicine (2021) 13:e12632. 10.15252/emmm.202012632 | Published online 11 January 2021

An IRB number is corrected in the Material and Methods section.

The final sentence under the subheading, ‘Human neuron culture’

is corrected from:

Protocols describing the use of human ESCs were approved in accordance with the ethical requirements and regulations of the Institutional Review Board of KAIST (IRB #KA2018‐61, KH2020‐55).

To: (Changes in bold).

Protocols describing the use of human ESCs were approved in accordance with the ethical requirements and regulations of the Institutional Review Board of KAIST (IRB #KH2017‐109).


Articles from EMBO Molecular Medicine are provided here courtesy of Nature Publishing Group

RESOURCES